{"groups":[{"description":"Arm 1: Methotrexate 30 mg/m2 IM weekly","id":"FG000","title":"Arm 1: Methotrexate 30 mg/m2 IM Weekly"},{"description":"Arm 2: Dactinomycin 1.25 mg/m2 IV push every 2 weeks","id":"FG001","title":"Arm 2: Dactinomycin 1.25 mg/m2 IV Push Every 2 Weeks"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"2"}],"type":"Ineligible cell types"},{"reasons":[{"groupId":"FG000","numSubjects":"8"},{"groupId":"FG001","numSubjects":"5"}],"type":"Did not meet criteria for persistence"},{"reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"1"}],"type":"WHO score > 6"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"3"}],"type":"Inadequate documentation of disease"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"120"},{"groupId":"FG001","numSubjects":"120"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"107"},{"groupId":"FG001","numSubjects":"109"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"13"},{"groupId":"FG001","numSubjects":"11"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"recruitmentDetails":"This trial opened to patient accrual on 6/14/1999 and closed to accrual on 2/26/2007."}